Infective endocarditis

Acta Clinica Belgica

Volumn 63, Issue 6, 2008, Pages 414-417

  Herregods, Marie Christine ^a   Hill, E ^a   Herijgers, P ^a   De Munter, P ^a   Vanderschueren, S ^a   Van Wijngaerden, E ^a   Peetermans, W E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Infective endocarditis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; EMBOLISM; ENTEROCOCCUS; HEART SURGERY; HUMAN; INCIDENCE; MORTALITY; PROGNOSIS; SEPTIC SHOCK; STAPHYLOCOCCUS; STREPTOCOCCUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION;

EID: 57849156267     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2008.085     Document Type: Conference Paper

References (10)

1. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007; 28(2): 196-203.
2. Hill EE, Vanderschueren S, Verhaegen J, et al. Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia. Mayo Clinic Proceedings 2007; 82(10): 1165-9.
3. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 220-2.
4. Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. The risk of embolism in infective endocarditis and effect on mortality. Eur J Clin Microbiol Infect Dis, 2008 July.
5. Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Abscess in infective endocarditis: the value of transoesophageal echocardiography and outcome. Am Heart J 2007; 154 (5): 923-8.
6. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK micro-organisms. American Heart Association. JAMA 1995; 274: 1706-13.
7. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summery. Eur Heart J 2004; 25: 267-76.
8. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young and the councils on clinical cardiology, stroke and cardiovascular surgery and anesthesia, American Heart Association - executive summary: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: 3167-84.
9. Hill EE, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P. Outcome of patients requiring valve surgery during active infective endocarditis. Ann Thorac Surg 2008; 85(5): 1564-9.
10. Hill EE, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P. Management of prosthetic valve infective endocarditis. Am J Cardiol 2008; 101(8): 1174-8.